M. Ronald Schaafsma

Phase III Study of the Value of Thalidomide Added to Melphalan Plus Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma: The HOVON 49 Study

Pierre W. Wijermans, M. Ronald Schaafsma, Fabian Termorshuizen et al. · Journal of Clinical Oncology · 2010 · 262 citations

Medicine, Oncology, Pharmacotherapy +17

Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells

Willem E. Fibbe, Frans H.J. Claas, Wies Van der Star‐Dijkstra et al. · British Journal of Haematology · 1986 · 100 citations

Medicine, Hematology, Immunology +16

Simultaneous production of interleukin 6, interferon‐β and colony‐stimulating activity by fibroblasts after viral and bacterial infection

Jo Van Damme, M. Ronald Schaafsma, Willem E. Fibbe et al. · European Journal of Immunology · 1989 · 91 citations

Veterinary Medicine, Immunology, Microbiology +13

Melphalan + Prednisone Versus Melphalan + Prednisone + Thalidomide in Induction Therapy for Multiple Myeloma in Elderly Patients: Final Analysis of the Dutch Cooperative Group HOVON 49 Study

P. Wijermans, M. Ronald Schaafsma, Yvette van Norden et al. · Blood · 2008 · 51 citations

Medicine, Geriatric Medicine, Oncology +17

Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high‐dose methotrexate, and R‐DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study

Jeanette K. Doorduijn, Gustaaf W. van Imhoff, Bronno van der Holt et al. · Hematological Oncology · 2016 · 45 citations · Full text

Medicine, Oncology, Pharmacotherapy +13